DTPa-HBV-IPV/Hib vaccine

BIOLOGICAL3 trials

Sponsors

GlaxoSmithKline

Conditions

Acellular PertussisDiphtheriaHaemophilus Influenzae Type bHepatitis BPoliomyelitisTetanus

Phase 3

Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules

CompletedNCT00316147

GlaxoSmithKlineAcellular Pertussis, Diphtheria, Haemophilus Influenzae Type b +3

Start: 2005-12-31End: 2006-08-31Target: 224Updated: 2016-09-28

Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants

CompletedNCT00320463

GlaxoSmithKlineAcellular Pertussis, Diphtheria, Hepatitis B +2

Start: 2006-04-30End: 2007-01-31Target: 415Updated: 2016-10-12

Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib Vaccine

CompletedNCT00880477

GlaxoSmithKlineHepatitis B

Start: 2001-01-31End: 2002-11-30Updated: 2016-09-07